Cargando…

Considerations for Clinical Therapeutic Development of Statins for Neurodevelopmental Disorders

Detalles Bibliográficos
Autores principales:	Ottenhoff, Myrthe J., Krab, Lianne C., Elgersma, Ype
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Neuroscience 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070444/ https://www.ncbi.nlm.nih.gov/pubmed/32071072 http://dx.doi.org/10.1523/ENEURO.0392-19.2020

Ejemplares similares

Marked Reduction of AKT1 Expression and Deregulation of AKT1-Associated Pathways in Peripheral Blood Mononuclear Cells of Schizophrenia Patients
por: van Beveren, Nico J. M., et al.
Publicado: (2012)

Motor Learning in Children with Neurofibromatosis Type I
por: Krab, Lianne C., et al.
Publicado: (2010)

Functional Gene-Expression Analysis Shows Involvement of Schizophrenia-Relevant Pathways in Patients with 22q11 Deletion Syndrome
por: van Beveren, Nico J. M., et al.
Publicado: (2012)

Correction: Functional Gene-Expression Analysis Shows Involvement of Schizophrenia-Relevant Pathways in Patients with 22q11 Deletion Syndrome
por: van Beveren, Nico J. M., et al.
Publicado: (2012)

hnRNPH2 gain-of-function mutations reveal therapeutic strategies and a role for RNA granules in neurodevelopmental disorders
por: Kelvington, Benjamin A., et al.
Publicado: (2023)

A Differential Effect of Lovastatin versus Simvastatin in Neurodevelopmental Disorders
por: Muscas, Melania, et al.
Publicado: (2020)

From first report to clinical trials: a bibliometric overview and visualization of the development of Angelman syndrome research
por: Zampeta, F. Isabella, et al.
Publicado: (2022)

Editorial: Biomarkers to Enable Therapeutics Development in Neurodevelopmental Disorders
por: Sahin, Mustafa, et al.
Publicado: (2020)

UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
por: Elgersma, Ype, et al.
Publicado: (2021)

Generating truth from error: insights from neurodevelopmental disorders
por: Jha, Ashwani, et al.
Publicado: (2019)

Transdiagnostic research and the neurodiversity paradigm: commentary on the transdiagnostic revolution in neurodevelopmental disorders by Astle et al.
por: Fletcher‐Watson, Sue
Publicado: (2022)

Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1
por: Ottenhoff, Myrthe J., et al.
Publicado: (2020)

Statins as modulators of bone formation
por: Edwards, Christopher J, et al.
Publicado: (2002)

A dysglycaemic effect of statins in diabetes: relevance to clinical practice?
por: Swerdlow, Daniel I., et al.
Publicado: (2014)

Considerations on the clinical development of COVID-19 vaccine from trial design perspectives
por: Jiang, Zhiwei, et al.
Publicado: (2020)

Considerations When Characterizing Adolescent Neurocognitive Development
por: Luna, Beatriz, et al.
Publicado: (2021)

Newborn screening for neurodevelopmental diseases: Are we there yet?
por: Chung, Wendy K., et al.
Publicado: (2022)

A brain proteomic investigation of rapamycin effects in the Tsc1(+/−) mouse model
por: Wesseling, Hendrik, et al.
Publicado: (2017)

Cultural considerations in the classification of mental disorders: why and how in ICD-11
por: Gureje, Oye, et al.
Publicado: (2020)

Cortical Inhibition and Plasticity in Major Depressive Disorder
por: Castricum, Jesminne, et al.
Publicado: (2022)

Cognitive performance outcomes: considerations for drug development
por: Zupan, Zorana
Publicado: (2023)

Current state of knowledge on the prevalence of neurodevelopmental disorders in childhood according to the DSM-5: a systematic review in accordance with the PRISMA criteria
por: Francés, Lorena, et al.
Publicado: (2022)

TAOK1 is associated with neurodevelopmental disorder and essential for neuronal maturation and cortical development
por: van Woerden, Geeske M., et al.
Publicado: (2021)

Statins, bone, and neurofibromatosis type 1
por: Korf, Bruce R
Publicado: (2008)

Statins, bugs and prophylaxis: intriguing possibilities
por: Terblanche, Marius, et al.
Publicado: (2006)

Statins STAT for (over)ventilated patients?
por: Kuebler, Wolfgang M
Publicado: (2010)

A new role for statins in sepsis
por: Rachoin, Jean-Sebastien, et al.
Publicado: (2013)

Statins in pneumonia - magic versus science?
por: Kruger, Peter S, et al.
Publicado: (2012)

Seeking biomarkers that predict neurodevelopmental impairment in preterm infants
por: Cascant-Vilaplana, Mari Merce, et al.
Publicado: (2021)

Ophthalmological Considerations for COVID-19 Vaccination in Patients with Inflammatory Eye Diseases and Autoimmune Disorders
por: Chau, Charlene Y. C., et al.
Publicado: (2021)

Postnatal therapeutic approaches in genetic neurodevelopmental disorders
por: Levy, Gilad, et al.
Publicado: (2020)

Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders
por: Kubota, Takeo, et al.
Publicado: (2012)

Considerations for the development and implementation of electronic immunization registries in Africa
por: Namageyo-Funa, Apophia, et al.
Publicado: (2018)

Building momentum for malaria vaccine research and development: key considerations
por: Chitnis, Chetan E., et al.
Publicado: (2020)

Key considerations for conducting Chinese medicine clinical trials in hospitals
por: Shergis, Johannah L, et al.
Publicado: (2013)

Statin discontinuation: counterbalancing the benefits with the potential risks
por: Paraskevas, Kosmas I., et al.
Publicado: (2011)

The role of statins as potential targets for bone formation
por: Garrett, I Ross, et al.
Publicado: (2002)

Do statins lower testosterone and does it matter?
por: Sniderman, Allan D, et al.
Publicado: (2013)

Statin effects on atherosclerotic plaques: regression or healing?
por: Bittencourt, Marcio Sommer, et al.
Publicado: (2015)

Statins as Inhibitors of Lung Cancer Bone Metastasis
por: Sarkar, Devanand
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pk9s249b5ouri4c91en4ii4dm7